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Abstract
Background:  We compare two new software packages for linkage analysis, LODPAL and
GENEFINDER. Both allow for covariate adjustment. Replicates 1 to 3 of Genetic Analysis
Workshop 13 simulated data sets were used for the analyses. We described the results of
searching for evidence of loci contributing to a simulated quantitative trait related to systolic blood
pressure (SBP). Individuals with SBP greater than 130 mm Hg were defined as affected individuals,
and all others as unaffected. Total cholesterol was treated as a covariate.
Results: Using LODPAL, the power of detecting one of the three major genes related to SBP is
44.4% when a LOD score of 1 is used as the cut-off point. The power of GENEFINDER is lower
than that of LODPAL. It is 22.2%.
Conclusions: Based on the limited comparison, LODPAL provided the more reasonable power
to detect linkage compared to GENEFINDER. After adjusting for the total cholesterol covariate,
the current version of both programs appeared to give a high number of false positives.
Background
There has been great interest in developing linkage analy-
sis methods that allow for the adjustment of covariates,
because this type of analysis can potentially allow us
greater power to detect genetic effects after adjusting traits
for the possible effect of covariates. The object of this
study is to compare the performance of two genetic
model-free linkage analysis software packages: LODPAL
and GENEFINDER. Below we present some brief theoret-
ical background on the two statistical methods imple-
mented in LODPAL and GENEFINDER.
LODPAL
LODPAL is an affected-relative-pair analysis method using
a conditional-logistic model that allows covariates to
adjust the relative risks associated with sharing alleles
identity by descent (IBD) [1]. Goddard et al. [2] modified
the two-parameter method originally described by Olson
[1] by assuming a mathematical relationship between the
two model parameters λ1 and λ2, where λ1 is the relative
risk for a pair of relatives that shares exactly one allele IBD
and λ2 is the relative risk for a pair of relatives that shares
two alleles IBD. Olson's original method requires two
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additional parameters for each covariate, while the new
method needs only one parameter by using the relation-
ship λ2 = 3.634 × λ1 - 2.634. This idea of parameter reduc-
tion was based on the work described by Whittmore and
Tu [3], in which they showed that a minimum-maximum
one-parameter ASP LOD score had better power for most
genetic models than traditional two-parameter models
when assuming a genetic model "approximately half way
between a recessive and a dominant mode of
inheritance".
GENEFINDER
Liang et al. [5] developed a multipoint linkage mapping
approach for estimating the location of a trait locus using
affected sibling pairs. This method makes an assumption
that there is no more than one trait locus in the chromo-
somal region. It has been implemented in the software
called GENEFINDER. The primary statistics are the
number of alleles shared IBD from multiple markers. The
model can be expressed as
E (S(t) | Φ) = 1 + (1-2θt,τ)2(E(S(τ) | Φ) - 1)
= 1 + (1-2θt,τ)2 × C,
where S(t) is the number of alleles shared IBD at an arbi-
trary locus t in the chromosomal region, Φ is the event of
affected siblings, θ is the recombination fraction between
locus t and the unobserved trait locus τ, and C is defined
as (E(S(τ) | Φ) - 1), which is the effect of the unobserved
trait locus as characterized by the excessive IBD sharing
due to the linkage to an unobserved trait locus. Using the
generalized estimating equation (GEE) procedure, we can
estimate the parameters of interest, τ and C, and their con-
fidence intervals, directly. An interesting feature of this
approach is that one can test the null hypothesis of no
linkage to this region by testing C = 0, which follows a χ2
distribution with 1 df. Furthermore, this GEE approach
has been extended to incorporate the linkage evidence
from unlinked regions [6] and to incorporate covariate
information [7]. When incorporating covariate data, the
model can be expressed as
E(S(t) | x ∈ l,Φ) = 1 + (1 -2θt,τ)2(E(S(τ) | x ∈ l, Φ) - 1)
= 1 + (1 - 2θt,τ)2 × Cl,
where x is the discrete covariate information, l(= 0, 1, 2) is
the value of this covariate, and Cl is defined as (E(S(τ) | Φ)
- 1) for the pairs with a covariate coded as 0, 1, and 2,
respectively. Similarly, we can estimate τ, Cl, and their
confidence intervals. One can test the null hypothesis of
no linkage to this region by testing C0 = C1 = C2 = 0, which
follows a χ2 distribution with 3 df.
Methods
Selection of phenotype and preliminary analysis
The details of the simulation data set of the Genetic Anal-
ysis Workshop 13 (GAW13) were described elsewhere [8].
We were interested in examining the power to detect link-
age using covariate-based linkage analysis methods using
Replicates 1 to 3 of the GAW13 data set. Particularly, we
selected systolic blood pressure (SBP) as our trait of inter-
est and dichotomized the trait by coding individuals with
SBP over 130 mm Hg as affected and all others as unaf-
fected. (We first considered using SBP over 140 mm Hg as
the threshold. However, there were not enough affected
pairs for the purpose of methodology evaluation with this
threshold.) For the sake of simplicity, we have only used
the phenotypic information from the first exam for each
individual. Presumably, at this earlier date, fewer individ-
uals had been medicated due to high blood pressure and/
or high cholesterol levels.
We identified 330 families with a total of 4692 individu-
als. The data contained the following relative pairs: par-
ent-offspring (5840), sib-sib (2798), grandparent-child
(6220), avuncular (2175), half-sib (77) and cousin
(1747). For LODPAL, 175 relative pairs from Replicate 1,
177 relative pairs from Replicate 2, and 199 relative pairs
from Replicate 3 with informative allele-sharing informa-
tion were included in the analyses. The covariate "total
cholesterol" was treated as a continuous variable.
Since the current version of GENEFINDER only allows for
affected sibling pairs, the information from pedigrees
with affected relative pairs other than siblings will be dis-
carded. For Replicate 1, 109 affected sibling pairs from 50
families were used; for Replicate 2, 107 affected sibling
pairs from 60 families were used; and for Replicate 3, 112
affected sibling pairs from 65 families were used. Since
GENEFINDER can only handle discrete covariates, we
dichotomized the total cholesterol based on a cut point at
200 mg/dl. Therefore, individuals with total cholesterol
greater than 200 mg/dl were considered to have high cho-
lesterol. Based on this classification, there were 48 sibling
pairs both with low cholesterol (LL), 44 pairs with only
one low cholesterol (HL), and 17 pairs both with high
cholesterol (HH) for Replicate 1. For Replicate 2, the
numbers of sibling pairs used for analysis were 37, 40, and
30, respectively. For Replicate 3, the numbers were 53, 41,
and 18, respectively. In our analysis, covariates for these
three scenarios were coded as l = 0, 1, and 2, respectively.
Linkage analysis
We performed a series of multipoint LODPAL analyses on
Replicates 1 to 3 of the GAW13 data using SAGE version
4.3 [9]. We also completed a series of multipoint linkage
analyses using GENEFINDER version 1.0 [10]. All 22
chromosomes from the three replicates were analyzed.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S46
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The results generated on the chromosomes containing
true loci related to SBP are then compared to those gener-
ated by GENEFINDER.
Results
For the LODPAL analysis, we chose to use a LOD score of
1 as the threshold for suggestive findings. Using this
threshold, we detected a total of one true locus on chro-
mosome 7 (LOD = 1.87, p-value = 0.0013) in Replicate 1,
two true loci on chromosome 5 (LOD = 4.629, p-value =
0.0029) and 13 (LOD = 3.699, p-value = 0.009) in Repli-
cate 2, and one true locus on chromosome 5 (LOD = 1.87,
p-value = 0.009) in Replicate 3 (see Figure 1). We defined
the "true-positive signal" to be a marker giving a LOD
score equal or greater than 1 and located less than 40 cM
from a true locus. The false-positive rates are 0.059 for
Replicate 1, 0.177 for Replicate 2, and 0.133 for Replicate
3.
For the GENEFINDER analysis, without adjusting for cov-
ariate, the significance of linkage evidence was detected
on chromosome 7 in Replicate 2 only (p-value = 0.049).
After adjusting for covariate, it was detected on chromo-
some 5 in Replicate 1 (p-value = 0.036) and chromosome
7 in Replicate 2 (p-value = 0.016). However, the estimates
of the locations of trait loci were not close to the true ones
on chromosomes 5 (at 176.08 cM) and 7 (at 47.49 cM).
Relatively, GENEFINDER located a trait locus closer to the
true location of quantitative trait locus B35 (at 85.16 cM)
on chromosome 13 in Replicates 1 and 2. Further, the
false-positive rates are much higher after adjusting for the
covariate when compared to those without adjusting for
the covariate (0.263 vs. 0.053 in Replicate 1; 0.316 vs.
0.105 in Replicate 2; 0.579 vs. 0.000 in Replicate 3); see
Table 1.
Discussion and Conclusions
Our analysis based on GAW13 simulated data showed
that the power to detect linkage in a complex trait is rea-
sonable using the LODPAL approach and the addition of
covariates increases the power to a certain extent (data not
shown). However, it is important to estimate empirical p-
values when using the LODPAL approach, especially
when the pedigree structure includes several pair types
with overlapping individuals [J.M. Olson, personal com-
munication]. The analysis based on the same simulation
data showed that the power to detect linkage for a com-
plex trait using the GENEFINDER approach is less power-
ful and the addition of covariate also increases power.
Although our comparison of LODPAL and GENEFINDER
is limited, there are still some points worth mentioning.
First, the addition of covariates increased the possibility of
getting a false-positive result in our analyses. Because total
cholesterol is a real risk factor for SBP, the models without
adjustment are less powerful when compared with those
with adjustment. Second, the appropriate selection of a
cut point for total cholesterol for GENEFINDER may have
had an impact on our power to detect linkage. An advan-
tage of using LODPAL is that one does not have to dichot-
omize covariates, because it naturally models continuous
covariates. Third, the cut point for SBP is 130 mm Hg,
which is lower than the normal cut-off of 140 mm Hg.
This may partly explain why we observed lower power,
but higher false positive rates. Fourth, unlike LODPAL,
GENEFINDER is designed to be used after previous evi-
dence of linkage has been found [5] because it can further
hone in on a chromosomal region of interest. This strategy
can also help reduce the false positives. In this paper, we
performed the GENEFINDER analysis for all the chromo-
somes. In other studies, we can focus on those regions
where the linkage evidence has been identified.
Furthermore, we stress the advantages and disadvantages
of these two methods. While both methods are model-
free and allow for the adjustment of covariates, LODPAL
also allows for continuous covariates not just categorical
ones. GENEFINDER, on the other hand, only allows for
categorical covariates, which presents a limitation. How-
ever, GENEFINDER can be used to test the location of an
unobserved trait locus and also provide its 95% confi-
dence interval. The other advantage is that GENEFINDER,
a multipoint approach, can also be used to test the null
hypothesis of no linkage using a test with 1 df without
adjusting for a covariate and with 3 df after adjusting for a
covariate. In LODPAL, as indicated by Goddard et al. [2],
the distribution of likelihood ratio statistic (LRS) for one
parameter is a 50:50 mixture of a point mass at 0 and a χ2
distribution with 1 df. Additional covariates gives an LRS
with a distribution that is a 50:50 mixture of a χ2 with k df
and a χ2 with (k+1) df. Also note that GENEFINDER is
sensitive to the initial values of the estimates. Therefore,
exploring different initial values to ensure that the solu-
tion reaches a global maximum is highly recommended
because it can help reach the convergent criteria.
Finally, we would like to note that using the programs we
evaluated required dichotomization of a quantitative trait
and therefore may cause a noticeable amount of power
loss. On the other hand, dichotomizing a trait such as
blood pressure is not an uncommon practice in real stud-
ies. Therefore, it is of interest to examine the power to
detect linkage under a situation where the design is less
than optimal. Since we only performed analyses on three
replicates (due to the limited time, computational
resources, and the relatively variable state of newly devel-
oped software), it is difficult to give solid guidelines to
future users. However, we would like to caution the users
with respect to the large number of false positives pro-
duced by both software packages.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S46
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Genome scan results of LODPAL for SBP on chromosomes 5, 7, and 13, where the true quantitative trait loci located (black,  Replicate 1; pink, Replicate 2; blue, Replicate 3) Figure 1
Genome scan results of LODPAL for SBP on chromosomes 5, 7, and 13, where the true quantitative trait loci located (black, 
Replicate 1; pink, Replicate 2; blue, Replicate 3).
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Figure 1. Genome scan results of LODPAL for SBP on chromosomes 5, 7, 
and 13 where the true quantitative trait loci located (Black: Replicate 1; Pink: 
Replicate 2; Blue: Replicate 3) 
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